# Influence of Obesity and IL-6 on Human Postprandial Amino Acid and Protein Metabolism at Whole-body and Tissue Level

**Authors:** Beckey Trinh, Signe Johanne Rasmussen, Mathilde Ehnhuus Brøgger-Jensen, Ana Rita Albuquerque de Almeida Tavanez, Anton Lund, Alexandra Vassilieva, Susanne Janum, Ulrik Winning Iepsen, Kirsten Møller, Bente Klarlund Pedersen, Gerrit Van Hall, Helga Ellingsgaard

PMC · DOI: 10.1210/clinem/dgaf547 · The Journal of Clinical Endocrinology and Metabolism · 2025-10-09

## TL;DR

Obesity reduces muscle-protein gain after meals due to impaired suppression of protein breakdown, and IL-6 affects amino acid metabolism but not muscle protein turnover.

## Contribution

The study reveals that IL-6 influences amino acid metabolism and extramuscular protein synthesis but not skeletal muscle protein turnover in obesity.

## Key findings

- Obesity is linked to reduced meal-induced muscle-protein gain due to impaired suppression of protein degradation.
- IL-6 receptor blockade increased plasma amino acids and reduced postprandial protein synthesis without affecting skeletal muscle turnover.
- Amino acid appearance and phenylalanine oxidation increased in the healthy weight group with IL-6 blockade.

## Abstract

Sarcopenic obesity, the loss of muscle mass and function in people with obesity, may result from altered muscle protein synthesis and degradation. Chronic low-grade inflammation, particularly IL-6, has been implicated.

To assess the role of IL-6 in protein and amino acid metabolism during fasting and postprandial states in humans with healthy weight or obesity at whole-body, skeletal muscle, and subcutaneous adipose tissue levels.

In this placebo-controlled, nonrandomized, participant-blinded study, 12 men with healthy weight and 12 men with obesity received placebo (0.9% saline) or 3 weeks of IL-6 receptor blockade with tocilizumab. Isotope dilution/incorporation techniques and arteriovenous balance measurements were applied in fasted and postprandial states. The trial was originally designed to examine IL-6 effects on fat storage (reported previously). Here, we present prespecified exploratory outcomes on amino acid and protein turnover.

Obesity was associated with reduced meal-induced muscle-protein gain driven by impaired suppression of muscle protein degradation, and with reduced appearance of amino acids from meals. In both groups, IL-6 receptor blockade increased fasting and postprandial plasma amino acids and reduced postprandial plasma protein synthesis without affecting skeletal muscle protein turnover. In the healthy weight group, it also increased amino acid appearance from the meal and postprandial phenylalanine oxidation.

Obesity impairs meal-induced muscle-protein gain, through insufficient suppression of protein degradation. Basal IL-6 activity does not regulate muscle protein turnover but influences amino acid metabolism and protein synthesis in extramuscular tissues.

## Linked entities

- **Proteins:** IL6 (interleukin 6)
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** Chronic low (MESH:D009800), inflammation (MESH:D007249), loss of muscle mass and function (MESH:D009135), Obesity (MESH:D009765)
- **Chemicals:** phenylalanine (MESH:D010649), amino acid (MESH:D000596), tocilizumab (MESH:C502936)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017920/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017920/full.md

## References

88 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017920/full.md

---
Source: https://tomesphere.com/paper/PMC13017920